Phlebitis and Candida albicans infection associated with relapsing erysipelas: a case report.
D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002176:Candida albicans / Q000302:isolation & purification; D002177:Candidiasis / Q000139:chemically induced / Q000150:complications*; D004886:Erysipelas / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D007868:Leg Dermatoses / Q000150:complications* / Q000188:drug therapy; D008200:Lymphangiectasis / Q000473:pathology; D008208:Lymphatic System / Q000473:pathology; D008220:Lymphography; D010118:Oxytetracycline / Q000009:adverse effects / Q000627:therapeutic use; D010689:Phlebitis / Q000188:drug therapy / Q000209:etiology*; D012008:Recurrence
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D010118:Oxytetracycline